background
novel
coronaviru
caus
outbreak
pneumonia
wuhan
hubei
provinc
china
isol
januari
studi
aim
investig
epidemiolog
histori
analyz
clinic
characterist
treatment
regimen
prognosi
patient
infect
outbreak
method
clinic
data
patient
admit
respiratori
depart
respiratori
depart
nine
tertiari
hospit
hubei
provinc
decemb
januari
retrospect
collect
includ
gener
statu
clinic
manifest
laboratori
test
result
imag
characterist
treatment
regimen
result
none
patient
male
femal
age
year
median
age
year
definit
histori
exposur
huanan
seafood
wholesal
market
major
initi
symptom
includ
fever
cough
muscl
pain
fatigu
less
typic
initi
symptom
observ
low
frequenc
includ
heart
palpit
diarrhea
headach
nearli
patient
normal
decreas
white
blood
cell
count
lymphocytopenia
lung
involv
present
case
chest
comput
tomographi
scan
show
lesion
multipl
lung
lobe
dens
groundglass
opac
coexist
consolid
shadow
cordlik
shadow
given
lack
effect
drug
treatment
focus
symptomat
respiratori
support
immunoglobulin
g
deliv
critic
ill
patient
accord
condit
system
corticosteroid
treatment
show
signific
benefit
notabl
earli
respiratori
support
facilit
diseas
recoveri
improv
prognosi
risk
death
primarili
associ
age
underli
chronic
diseas
median
interv
appear
initi
symptom
dyspnea
conclus
major
patient
pneumonia
present
fever
first
symptom
still
show
typic
manifest
viral
pneumonia
chest
imag
middleag
elderli
patient
underli
comorbid
suscept
respiratori
failur
may
poorer
prognosi
late
wuhan
hubei
provinc
china
becam
focu
world
owe
outbreak
pneumonia
unknown
etiolog
pathogen
success
isol
januari
name
novel
coronaviru
pm
beij
time
januari
confirm
case
worldwid
half
hubei
provinc
report
clinic
manifest
laboratori
test
result
imag
characterist
treatment
regimen
patient
admit
respiratori
depart
sever
tertiari
hospit
hubei
provid
basi
specif
diagnosi
treatment
protocol
diseas
studi
conduct
accord
declar
helsinki
inform
consent
waiv
retrospect
natur
studi
analysi
use
anonym
clinic
data
data
analyz
patient
admit
respiratori
depart
identifi
nucleic
acidposit
nine
tertiari
hospit
hubei
provinc
decemb
januari
patient
male
femal
age
rang
year
median
age
year
mean
age
year
inclus
procedur
criteria
follow
suspect
case
screen
accord
diagnosi
treatment
protocol
novel
coronaviru
pneumonia
npc
select
respiratori
tract
secret
sampl
acquir
realtim
fluoresc
revers
transcriptionpolymeras
chain
reaction
rtpcr
patient
test
posit
nucleic
acid
cov
identifi
confirm
case
enrol
studi
admiss
hospit
respiratori
tract
sampl
includ
sputum
nasopharyng
swab
collect
patient
test
influenza
avian
influenza
respiratori
syncyti
viru
adenoviru
parainfluenza
viru
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
along
routin
bacteri
fungal
pathogen
microorgan
test
respiratori
sampl
employ
realtim
fluorescencebas
rtpcr
detect
presenc
total
rna
extract
use
trizol
accord
manufactur
instruct
rtpcr
perform
accord
manufactur
instruct
use
nucleic
acid
detect
kit
biogerm
shanghai
china
follow
primer
probe
cov
envelop
gene
use
forward
primer
revers
primer
probe
amplif
condit
min
min
follow
cycl
basic
inform
age
gender
smoke
histori
comorbid
collect
patient
addit
epidemiolog
histori
taken
includ
longtim
vendor
employe
worker
huanan
seafood
wholesal
market
decemb
staff
conduct
h
work
process
sale
slaughter
treatment
transport
activ
huanan
seafood
wholesal
market
week
prior
diseas
onset
decemb
definit
histori
contact
bird
wildlif
huanan
seafood
wholesal
market
week
prior
diseas
onset
decemb
close
contact
individu
suspect
confirm
infect
viru
common
transport
stay
room
clinic
manifest
record
fever
coughingexpectorationmyalgia
fatiguehemoptysisheadacheheart
palpitationsdiarrheadyspnea
etc
along
diseas
condit
chang
laboratori
test
result
compil
includ
standard
blood
count
absolut
white
blood
cell
lymphocyt
blood
biochemistri
alanin
transaminas
aspart
transaminas
creatin
kinas
creatinin
coagul
function
procalcitonin
creactiv
protein
erythrocyt
sediment
rate
myocardi
enzym
spectrum
addit
data
collect
includ
medic
imag
treatment
regimen
antivir
antibacteri
system
corticosteroid
immunoglobulin
g
respiratori
support
prognosi
recov
discharg
inpati
treatment
death
continu
data
express
median
rang
sinc
nonnorm
distribut
data
check
normal
distribut
kolmogorovsmirnov
test
categor
data
present
count
percentag
half
confirm
case
includ
studi
wuhan
accord
epidemiolog
histori
patient
admit
hospit
citi
hubei
provinc
predominantli
origin
wuhan
figur
basic
characterist
studi
popul
summar
tabl
median
mean
age
patient
year
respect
suggest
middleag
elderli
peopl
suscept
infect
wherea
healthi
young
adult
patient
less
suscept
addit
none
patient
includ
studi
clear
histori
exposur
wuhan
huanan
seafood
wholesal
market
suggest
viru
capabl
secondari
tertiari
transmiss
highlight
extrem
likelihood
humanhuman
transmiss
align
current
nation
epidem
situat
moreov
critic
ill
patient
frequent
underli
comorbid
system
diseas
result
poor
prognosi
shown
tabl
major
patient
show
initi
symptom
fever
nearli
half
develop
high
fever
contrast
one
fifth
patient
develop
fever
alert
need
caution
atyp
case
addit
fever
major
symptom
cough
myalgia
fatigu
patient
develop
initi
symptom
cardiovascular
system
digest
system
nervou
system
increas
difficulti
diagnosi
median
interv
onset
initi
symptom
dyspnea
signific
symptom
aggrav
day
rang
day
ie
appear
acut
respiratori
distress
syndrom
day
consist
previou
report
nearli
patient
show
comorbid
respect
dysfunct
organ
primarili
renal
impair
patient
underli
cardiovascular
diseas
often
demonstr
comorbid
heart
failur
sinc
respiratori
support
administ
patient
upon
admiss
blood
oxygen
satur
could
maintain
indic
puls
oximetri
monitor
definit
diagnosi
acquir
realtim
fluorescencebas
rtpcr
shown
tabl
patient
normal
decreas
white
blood
cell
count
patient
figur
show
repres
lung
imag
patient
lesion
develop
multipl
lobe
dens
groundglass
opac
coexist
consolid
cordlik
shadow
present
drug
avail
target
cov
therefor
treatment
focus
symptomat
respiratori
support
tabl
patient
rapid
progress
median
interv
onset
initi
symptom
dyspnea
less
day
recommend
respiratori
support
administ
soon
possibl
gimmunoglobulin
administ
base
patient
condit
although
clear
medic
evid
avail
intraven
methylprednisolon
mgday
still
provid
patient
either
suffer
persist
high
fever
subsid
show
signific
shortterm
diseas
progress
determin
imag
result
base
mechan
action
drug
expect
system
corticosteroid
treatment
could
inhibit
cytokin
storm
promot
absorpt
exud
lesion
howev
treatment
neither
significantli
shorten
diseas
cours
improv
prognosi
exampl
imag
figur
patient
treat
mg
intraven
iv
everi
day
qd
methylprednisolon
admiss
day
treatment
review
lung
comput
tomographi
ct
scan
show
signific
lesion
progress
patient
ultim
die
indic
lung
chang
caus
none
patient
current
invas
respiratori
support
extracorpor
membran
oxygen
ecmo
like
patient
includ
studi
predominantli
admit
respiratori
depart
therefor
relev
data
intens
care
unit
depart
insuffici
could
lead
bias
conclus
sixteen
patient
eventu
die
complic
infect
higher
mortal
rate
previous
report
might
attribut
fact
inpati
critic
condit
patient
infect
outbreak
cov
envelop
rna
viru
ubiquit
human
mammal
bird
caus
respiratori
digest
liver
nervou
system
disord
date
six
cov
known
caus
human
infect
among
two
zoonot
virus
sarscov
merscov
respons
seriou
outbreak
china
middl
east
respect
addit
crossspeci
infect
occasion
spillov
event
may
lead
cyclic
emerg
new
cov
decemb
pneumonia
unknown
etiolog
appear
wuhan
hubei
provinc
caus
sinc
confirm
particular
concern
observ
found
patient
clear
histori
exposur
wuhan
huanan
seafood
wholesal
market
suggest
strong
likelihood
signific
humantohuman
transmiss
diseas
meantim
rapid
increas
case
across
countri
far
confirm
viru
humantohuman
transmiss
rapid
spread
reminisc
sar
outbreak
china
although
widespread
transmiss
sar
viru
success
prevent
owe
inadequ
experi
outbreak
natur
time
sarscov
still
caus
infect
lead
death
typic
clinic
manifest
sar
includ
sudden
fever
usual
accompani
chill
headach
myalgia
fatigu
cough
patient
also
develop
signific
respiratori
distress
within
short
period
laboratori
test
show
either
normal
decreas
peripher
white
blood
cell
count
imag
show
focal
patchlik
shadow
reticular
exud
although
rapidli
progress
diffus
consolid
patient
present
cohort
patient
typic
initi
symptom
ncp
primarili
fever
high
fever
occur
within
sever
day
allevi
routin
antiinfect
drug
howev
middleag
elderli
patient
underli
comorbid
develop
moder
low
fever
diseas
cours
addit
patient
suffer
fatigu
dri
cough
diseas
onset
nevertheless
atyp
initi
symptom
deserv
similar
attent
common
symptom
exampl
report
patient
ncp
present
diarrhea
initi
symptom
diseas
onset
patient
present
elev
troponin
level
myocard
other
develop
headach
myalgia
symptom
similar
influenza
emphas
author
observ
patient
outpati
clinic
even
obviou
symptom
came
see
doctor
discomfort
moreov
previou
studi
report
one
asymptomat
patient
diagnos
infect
therefor
presenc
asymptomat
carrier
requir
due
attent
relev
contact
track
isol
soon
possibl
studi
routin
peripher
blood
test
show
either
normal
decreas
white
blood
cell
count
lymphocytopenia
well
elev
creactiv
protein
erythrocyt
sediment
rate
gener
consist
previou
report
patient
ncp
patient
earlystag
lung
ct
scan
mostli
show
multipl
small
patchlik
shadow
interstiti
chang
obviou
extrapulmonari
region
shadow
subsequ
progress
multipl
groundglass
opac
lung
along
infiltr
shadow
larg
white
lung
observ
sever
case
median
interv
onset
initi
symptom
dyspnea
day
sever
case
diseas
rapidli
progress
acut
respiratori
distress
syndrom
septic
shock
refractori
metabol
acidosi
coagul
disord
eventu
lead
death
base
present
data
mortal
rate
lower
sar
moreov
notabl
epidemiolog
differ
two
outbreak
exampl
critic
ill
sar
patient
young
adult
requir
invas
ventil
treatment
wherea
critic
ill
patient
includ
studi
middleag
elderli
peopl
age
differ
may
contribut
poor
prognosi
case
thu
proport
young
adult
patient
sar
moder
sever
diseas
substanti
higher
young
adult
patient
howev
reason
take
new
threat
serious
although
mortal
caus
seemingli
lower
sar
incub
period
may
longer
produc
much
larger
number
potenti
asymptomat
carrier
possibl
impos
pressur
secur
definit
diagnosi
diseas
contain
transmiss
base
experi
lesson
learn
sar
mer
outbreak
treatment
site
protocol
confirm
case
ncp
decid
diseas
sever
patient
mild
symptom
ie
cough
lowgrad
fever
runni
nose
asymptomat
sore
throat
quarantin
home
wherea
patient
moder
sever
diseas
hospit
treatment
studi
cohort
includ
patient
alreadi
critic
ill
current
effect
drug
symptomat
treatment
respiratori
support
provid
sinc
largedos
glucocorticoid
use
treatment
sar
result
seriou
advers
reaction
effect
decreas
mortal
rate
cov
infect
treat
patient
lowdos
mgday
shortterm
day
methylpredisolon
allevi
pulmonari
exud
inhibit
system
cytokin
storm
unfortun
treatment
provid
signific
benefit
altern
intraven
inject
gimmunoglobulin
offer
howev
clinic
data
requir
determin
efficaci
treatment
middl
late
stage
diseas
patient
often
develop
addit
bacteri
even
fungal
infect
therefor
care
attent
must
paid
ration
use
antibiot
addit
aforement
treatment
respiratori
support
provid
earli
possibl
cohort
differ
type
oxygen
therapi
administ
accord
patient
puls
oximetri
oxygen
satur
oxygen
index
patient
earli
noninvas
ventil
could
promot
posit
outcom
altern
critic
ill
patient
invas
ventil
even
ecmo
consid
date
ecmo
success
use
resuscit
one
critic
ill
patient
infect
new
cov
sever
drug
alreadi
test
relev
clinic
observ
studi
initi
encourag
preliminari
result
particular
research
anticoronavir
drug
vaccin
continu
prioriti
none
current
test
treatment
use
cohort
patient
thu
efficaci
remain
unknown
studi
limit
exampl
patient
includ
studi
inpati
sampl
size
rel
small
collect
analyz
data
outpati
mild
symptom
suspect
patient
home
observ
await
definit
diagnosi
may
result
bia
gener
understand
diseas
addit
sinc
patient
studi
admit
respiratori
depart
tertiari
hospit
hubei
provinc
data
intens
care
unit
depart
insuffici
similarli
lead
bias
understand
diseas
basi
broader
larger
studi
necessari
immedi
futur
conclus
analyz
confirm
case
infect
tertiari
hospit
hubei
provinc
preliminarili
identifi
major
clinic
characterist
correspond
treatment
principl
diseas
howev
still
larg
gap
understand
origin
epidemiolog
persist
human
transmiss
diseas
therefor
continu
monitor
trace
requir
secur
indepth
understand
diseas
therebi
provid
improv
evidentiari
basi
standard
diagnosi
treatment
none
chines
medic
journal
vol
wwwcmjorg
